Actinogen Medical Statistics

Total Valuation

ASX:ACW has a market cap or net worth of AUD 87.70 million. The enterprise value is 65.12 million.

Market Cap	87.70M
Enterprise Value	65.12M

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:ACW has 3.13 billion shares outstanding. The number of shares has increased by 35.04% in one year.

Current Share Class	n/a
Shares Outstanding	3.13B
Shares Change (YoY)	+35.04%
Shares Change (QoQ)	+27.69%
Owned by Insiders (%)	13.56%
Owned by Institutions (%)	2.66%
Float	2.36B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.72
PB Ratio	3.66
P/TBV Ratio	3.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.74
EV / Sales	7.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.46

Financial Position

The company has a current ratio of 18.76, with a Debt / Equity ratio of 0.01.

Current Ratio	18.76
Quick Ratio	18.73
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-296.71

Financial Efficiency

Return on equity (ROE) is -53.73% and return on invested capital (ROIC) is -34.33%.

Return on Equity (ROE)	-53.73%
Return on Assets (ROA)	-31.46%
Return on Invested Capital (ROIC)	-34.33%
Return on Capital Employed (ROCE)	-41.19%
Revenue Per Employee	1.50M
Profits Per Employee	-1.61M
Employee Count	6
Asset Turnover	0.46
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.10% in the last 52 weeks. The beta is 1.13, so ASX:ACW's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	-2.10%
50-Day Moving Average	0.03
200-Day Moving Average	0.03
Relative Strength Index (RSI)	43.46
Average Volume (20 Days)	6,421,826

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ACW had revenue of AUD 9.02 million and -9.66 million in losses. Loss per share was -0.00.

Revenue	9.02M
Gross Profit	9.02M
Operating Income	-9.96M
Pretax Income	-9.66M
Net Income	-9.66M
EBITDA	-9.64M
EBIT	-9.96M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 22.87 million in cash and 289,645 in debt, giving a net cash position of 22.58 million or 0.01 per share.

Cash & Cash Equivalents	22.87M
Total Debt	289,645
Net Cash	22.58M
Net Cash Per Share	0.01
Equity (Book Value)	23.97M
Book Value Per Share	0.01
Working Capital	21.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.72 million and capital expenditures -9,026, giving a free cash flow of -8.73 million.

Operating Cash Flow	-8.72M
Capital Expenditures	-9,026
Free Cash Flow	-8.73M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -110.44% and -107.03%.

Gross Margin	100.00%
Operating Margin	-110.44%
Pretax Margin	-107.03%
Profit Margin	-107.03%
EBITDA Margin	-106.83%
EBIT Margin	-110.44%
FCF Margin	n/a

Dividends & Yields

ASX:ACW does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.04%
Shareholder Yield	-35.04%
Earnings Yield	-11.01%
FCF Yield	-9.95%

Stock Splits

The last stock split was on December 3, 2013. It was a reverse split with a ratio of 0.5.

Last Split Date	Dec 3, 2013
Split Type	Reverse
Split Ratio	0.5

Scores

ASX:ACW has an Altman Z-Score of 32.7.

Altman Z-Score	32.7
Piotroski F-Score	n/a